MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12977-016-0244-2

Медицинская библиотека · Retrovirology · 2016

Rilpivirine analogs potently inhibit drug-resistant HIV-1 mutants.

Smith Steven J, Pauly Gary T, Akram Aamir, Melody Kevin, Rai Ganesha, Maloney David J, Ambrose Zandrea, Thomas Craig J, Schneider Joel T, Hughes Stephen H

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Nonnucleoside reverse transcriptase inhibitors (NNRTIs) are a class of antiretroviral compounds that bind in an allosteric binding pocket in HIV-1 RT, located about 10 Å from the polymerase active site. Binding of an NNRTI causes structural changes that perturb the alignment of the primer terminus and polymerase active site, preventing viral DNA synthesis. Rilpivirine (RPV) is the most recent NNRTI approved by the FDA, but like all other HIV-1 drugs, suboptimal treatment can lead to the development of resistance. To generate better compounds that could be added to the current HIV-1 drug armamentarium, we have developed several RPV analogs to combat viral variants that are resistant to the available NNRTIs.

RESULTS

Using a single-round infection assay, we identified several RPV analogs that potently inhibited a broad panel of NNRTI resistant mutants. Additionally, we determined that several resistant mutants selected by either RPV or Doravirine (DOR) caused only a small increase in susceptibility to the most promising RPV analogs.

CONCLUSIONS

The antiviral data suggested that there are RPV analogs that could be candidates for further development as NNRTIs, and one of the most promising compounds was modeled in the NNRTI binding pocket. This model can be used to explain why this compound is broadly effective against the panel of NNRTI resistance mutants.

Для цитирования: Smith Steven J, Pauly Gary T, Akram Aamir, Melody Kevin, Rai Ganesha, Maloney David J, Ambrose Zandrea, Thomas Craig J, Schneider Joel T, Hughes Stephen H. Rilpivirine analogs potently inhibit drug-resistant HIV-1 mutants.. Retrovirology. 2016. DOI: 10.1186/s12977-016-0244-2.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.